Uniphar (LON:UPR) Shares Down 1.4% - Here's Why

Uniphar plc (LON:UPR - Get Free Report)'s share price traded down 1.4% during trading on Thursday . The company traded as low as GBX 226 ($2.89) and last traded at GBX 228.75 ($2.92). 141,010 shares traded hands during mid-day trading, an increase of 316% from the average session volume of 33,865 shares. The stock had previously closed at GBX 232 ($2.96).

Analyst Upgrades and Downgrades

Separately, Shore Capital reiterated a "buy" rating on shares of Uniphar in a report on Tuesday, February 25th.

Uniphar Stock Performance

The stock has a market cap of £703.50 million, a price-to-earnings ratio of 15.71 and a beta of 0.75. The company's fifty day simple moving average is GBX 215.71 and its two-hundred day simple moving average is GBX 197.05. The company has a debt-to-equity ratio of 119.48, a current ratio of 0.90 and a quick ratio of 0.60.

Uniphar Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, May 16th. Investors of record on Thursday, April 24th will be issued a €0.01 ($0.01) dividend. This represents a dividend yield of 0.47%. The ex-dividend date of this dividend is Thursday, April 24th. This is a positive change from Uniphar's previous dividend of $0.01. Uniphar's dividend payout ratio is currently 13.91%.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.